{"transactions":[{"id":692952,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:35.000Z","date":"2026-07-21","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":1.4,"value":4900.0,"ownership":{"direct":true},"balance_after":112420,"source":{"system":"sec-edgar","filing":"0001493152-26-036583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000149315226036583/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-23"}},{"id":703963,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"COMMON STOCK","published_at":"2026-07-23T20:15:25.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":1.4,"value":4900.0,"ownership":{"direct":true},"balance_after":112420,"source":{"system":"sec-edgar","filing":"0001493152-26-034406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000149315226034406/ownership.xml","form_type":"4"}},{"id":1628554,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-02-22T01:01:44.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":102120,"derivative":{"exercise_price":2.56,"exercise_date":"2024-02-19","expiration_date":"2026-02-19","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001493152-24-007462","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000149315224007462/ownership.xml","form_type":"4"}},{"id":2263430,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"American Depositary Shares","published_at":"2022-05-19T15:14:55.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":12500,"price":4,"value":50000.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001493152-22-014438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000149315222014438/ownership.xml","form_type":"4"}},{"id":2444095,"issuer":{"id":84306,"kind":"organization","name":"Virpax Pharmaceuticals, Inc.","symbol":"VRPX"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T17:18:59.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":12091,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12091,"derivative":{"exercise_price":3.43,"exercise_date":"2023-01-01","expiration_date":"2032-01-01","underlying":"Common Stock","underlying_shares":12091},"source":{"system":"sec-edgar","filing":"0000905718-22-000024","document":"virpax_fm4jan12022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708331/000090571822000024/virpax_fm4jan12022.xml","form_type":"4"}},{"id":2668041,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":44734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":2.48,"exercise_date":"2020-06-20","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":44734},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668040,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":21.6,"exercise_date":"2019-01-23","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":755},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668039,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":51.84,"exercise_date":"2018-10-04","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":530},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668038,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":372.96,"exercise_date":"2017-01-04","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668037,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":516.96,"exercise_date":"2016-03-17","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668036,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":316.08,"exercise_date":"2014-12-11","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":218},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668035,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Expiration date of the stock options was extended to June 10, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"8,805 of the stock options vest immediately.  4,077 of the stock options vest on each of 2/25/2015 and 2016 and 4,076 of the stock options vest on 2/25/2017."}],"balance_after":76106,"derivative":{"exercise_price":447.84,"expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":293},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2668034,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-15T14:06:43.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":28858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 28,858 stock options to June 10, 2021 from June 17, 2021. In addition, the Compensation Committee extended the expiration date of the stock options to June 10, 2023."}],"balance_after":76106,"derivative":{"exercise_price":2.6,"exercise_date":"2021-06-10","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":28858},"source":{"system":"sec-edgar","filing":"0001628280-21-012225","document":"wf-form4_162376598346799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021012225/wf-form4_162376598346799.xml","form_type":"4"}},{"id":2702805,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T20:36:51.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":342785,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-21-069940","document":"tm2117144d6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465921069940/tm2117144d6_4seq1.xml","form_type":"4"}},{"id":2752176,"issuer":{"id":84306,"kind":"organization","name":"Virpax Pharmaceuticals, Inc.","symbol":"VRPX"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-09T17:00:26.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":13183,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13183,"derivative":{"exercise_price":4.62,"exercise_date":"2022-04-07","expiration_date":"2031-04-07","underlying":"Common Stock","underlying_shares":13183},"source":{"system":"sec-edgar","filing":"0000905718-21-000570","document":"jacob_fm4april72021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708331/000090571821000570/jacob_fm4april72021.xml","form_type":"4"}},{"id":2774496,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-23T19:57:14.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":470,"price":10.395,"value":4885.65,"ownership":{"direct":true},"balance_after":21922,"source":{"system":"sec-edgar","filing":"0001628280-21-005358","document":"wf-form4_161652942189444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021005358/wf-form4_161652942189444.xml","form_type":"4"}},{"id":2774495,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-23T19:57:14.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":1900,"price":10.423,"value":19803.7,"ownership":{"direct":true},"balance_after":21452,"source":{"system":"sec-edgar","filing":"0001628280-21-005358","document":"wf-form4_161652942189444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000162828021005358/wf-form4_161652942189444.xml","form_type":"4"}},{"id":2846354,"issuer":{"id":84306,"kind":"organization","name":"Virpax Pharmaceuticals, Inc.","symbol":"VRPX"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.00001 par value","published_at":"2021-02-19T18:22:07.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":3500,"price":6.789,"value":23761.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001213900-21-010660","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708331/000121390021010660/ownership.xml","form_type":"4"}},{"id":2962568,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T00:53:08.000Z","date":"2020-12-01","kind":"purchase","acquired":true,"shares":12000,"price":1.66,"value":19920.0,"ownership":{"direct":true},"balance_after":12059,"source":{"system":"sec-edgar","filing":"0001104659-20-131213","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465920131213/a4.xml","form_type":"4"}},{"id":3049749,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T20:15:43.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92785,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097593","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465920097593/a4.xml","form_type":"4"}},{"id":3104146,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-19T20:16:19.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":28858,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76106,"derivative":{"exercise_price":2.6,"exercise_date":"2021-06-17","expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":28858},"source":{"system":"sec-edgar","filing":"0001104659-20-075237","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465920075237/a4.xml","form_type":"4"}},{"id":3145195,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T20:16:26.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":17483,"price":1.43,"value":25000.69,"ownership":{"direct":true},"balance_after":19552,"source":{"system":"sec-edgar","filing":"0001104659-20-063177","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465920063177/a4.xml","form_type":"4"}},{"id":3180473,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-04-07T20:13:26.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62729,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044169","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465920044169/a4.xml","form_type":"4"}},{"id":3455921,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T20:16:21.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2729,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041850","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465919041850/a4.xml","form_type":"4"}},{"id":3479935,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-06-24T20:07:17.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":44734,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48071,"derivative":{"exercise_price":2.48,"exercise_date":"2020-06-20","expiration_date":"2019-06-20","underlying":"Common Stock","underlying_shares":44734},"source":{"system":"sec-edgar","filing":"0000899243-19-017923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000089924319017923/doc4.xml","form_type":"4"}},{"id":3874537,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-07-03T18:17:43.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":8625,"price":1000,"value":8625000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"}],"balance_after":8625,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","expiration_date":"2023-07-03","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001104659-18-043798","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918043798/a4.xml","form_type":"4"}},{"id":3874536,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-03T18:17:43.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":15,"price":1000,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C Convertible Preferred Stock do not expire."}],"balance_after":15,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","underlying":"Common Stock","underlying_shares":9678},"source":{"system":"sec-edgar","filing":"0001104659-18-043798","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918043798/a4.xml","form_type":"4"}},{"id":3890509,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options","published_at":"2018-06-18T20:30:42.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":474961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,320 options vested on 7/3/2009 and 7/3/2010 and 158,321 vested on 7/3/2011"}],"balance_after":6513342,"derivative":{"exercise_price":0.5,"expiration_date":"2018-07-03","underlying":"Common Stock","underlying_shares":474961},"source":{"system":"sec-edgar","filing":"0001104659-18-040813","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918040813/a4.xml","form_type":"4"}},{"id":3890508,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-06-18T20:30:42.000Z","date":"2018-06-15","kind":"tax_withholding","acquired":false,"shares":150246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person is reporting the withholding by Synergy Pharmaceuticals Inc. of 150,246 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the exercise of the stock options on June 15, 2018."}],"balance_after":595460,"source":{"system":"sec-edgar","filing":"0001104659-18-040813","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918040813/a4.xml","form_type":"4"}},{"id":3890507,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-06-18T20:30:42.000Z","date":"2018-06-15","kind":"tax_withholding","acquired":false,"shares":131934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares forfeited to the Company in payment of the exercise price of the stock options."}],"balance_after":745706,"source":{"system":"sec-edgar","filing":"0001104659-18-040813","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918040813/a4.xml","form_type":"4"}},{"id":3890506,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-06-18T20:30:42.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":474961,"price":0.5,"value":237480.5,"ownership":{"direct":true},"balance_after":877640,"source":{"system":"sec-edgar","filing":"0001104659-18-040813","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918040813/a4.xml","form_type":"4"}},{"id":4089600,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-01-25T22:00:25.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":54322,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":248101,"derivative":{"exercise_price":0.3,"exercise_date":"2019-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":54322},"source":{"system":"sec-edgar","filing":"0000899243-18-001899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000089924318001899/doc4.xml","form_type":"4"}},{"id":4102863,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options","published_at":"2018-01-09T22:02:06.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":950000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"316,667 options vest on each of 1/5/2019 and 2020 and 316,666 vest on 1/5/2021."}],"balance_after":6988303,"derivative":{"exercise_price":2.18,"expiration_date":"2028-01-05","underlying":"Common Stock","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001104659-18-001494","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465918001494/a4.xml","form_type":"4"}},{"id":4107184,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-01-04T22:15:46.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. The common stock into which such vested restricted stock units converted on January 2, 2018 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. The common stock into which such vested restricted stock units converted on January 2, 2018 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000899243-18-000482","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000089924318000482/doc4.xml","form_type":"4"}},{"id":4107183,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T22:15:46.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock (the \"Converted Common Stock\"). On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017."}],"balance_after":148954,"source":{"system":"sec-edgar","filing":"0000899243-18-000482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000089924318000482/doc4.xml","form_type":"4"}},{"id":4190903,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-10-05T20:19:28.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":38106,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":193779,"derivative":{"exercise_price":0.72,"exercise_date":"2018-10-04","expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":38106},"source":{"system":"sec-edgar","filing":"0001104659-17-061153","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917061153/a4.xml","form_type":"4"}},{"id":4215791,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-09-07T00:56:28.000Z","date":"2017-09-02","kind":"exercise","acquired":false,"shares":9287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 9,287 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 9,287 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-17-055901","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917055901/a4.xml","form_type":"4"}},{"id":4215790,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T00:56:28.000Z","date":"2017-09-02","kind":"exercise","acquired":true,"shares":9287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock (the \"Converted Common Stock\"). On January 2, 2017, the reporting person was granted 9,287 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017."}],"balance_after":132287,"source":{"system":"sec-edgar","filing":"0001104659-17-055901","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917055901/a4.xml","form_type":"4"}},{"id":4269101,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Stock Options","published_at":"2017-06-30T21:09:08.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on February 25, 2010. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."}],"balance_after":6038303,"derivative":{"exercise_price":1.4,"exercise_date":"2017-06-28","expiration_date":"2020-02-25","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001104659-17-043013","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917043013/a4.xml","form_type":"4"}},{"id":4269100,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Stock Options","published_at":"2017-06-30T21:09:08.000Z","date":"2017-06-28","kind":"disposition_to_issuer","acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on February 25, 2010. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on February 25, 2010. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."}],"balance_after":5138202,"derivative":{"exercise_price":1.4,"expiration_date":"2020-02-25","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001104659-17-043013","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917043013/a4.xml","form_type":"4"}},{"id":4301092,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-30T11:55:18.000Z","date":"2017-05-26","kind":"purchase","acquired":true,"shares":5680,"price":3.5154,"value":19967.472,"ownership":{"direct":true},"balance_after":402679,"source":{"system":"sec-edgar","filing":"0001104659-17-035883","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917035883/a4.xml","form_type":"4"}},{"id":4498232,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-05T21:56:41.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":9287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest on September 2, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest on September 2, 2017."}],"balance_after":25954,"derivative":{"underlying":"Common Stock","underlying_shares":9287},"source":{"system":"sec-edgar","filing":"0001104659-17-000960","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917000960/a4a.xml","form_type":"4/A","original_submission_date":"2017-01-04"}},{"id":4498231,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-05T21:56:41.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-17-000960","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917000960/a4a.xml","form_type":"4/A","original_submission_date":"2017-01-04"}},{"id":4502157,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-04T22:00:56.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-17-000629","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000110465917000629/a4.xml","form_type":"4"}}]}